8-144051350-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1
The ENST00000618853.5(OPLAH):āc.3843T>Cā(p.Tyr1281=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000757 in 1,611,366 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.00044 ( 0 hom., cov: 32)
Exomes š: 0.000038 ( 0 hom. )
Consequence
OPLAH
ENST00000618853.5 synonymous
ENST00000618853.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.02
Genes affected
OPLAH (HGNC:8149): (5-oxoprolinase, ATP-hydrolysing) The protein encoded by this gene acts as a homodimer, using ATP hydrolysis to catalyze the conversion of 5-oxo-L-proline to L-glutamate. Defects in this gene are a cause of 5-oxoprolinase deficiency (OPLAHD). [provided by RefSeq, Jun 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 8-144051350-A-G is Benign according to our data. Variant chr8-144051350-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 1134698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00044 (67/152292) while in subpopulation AFR AF= 0.00152 (63/41572). AF 95% confidence interval is 0.00121. There are 0 homozygotes in gnomad4. There are 30 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OPLAH | NM_017570.5 | c.3843T>C | p.Tyr1281= | synonymous_variant | 27/27 | ENST00000618853.5 | NP_060040.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OPLAH | ENST00000618853.5 | c.3843T>C | p.Tyr1281= | synonymous_variant | 27/27 | 1 | NM_017570.5 | ENSP00000480476 | P1 | |
ENST00000528912.1 | n.1218A>G | non_coding_transcript_exon_variant | 5/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000440 AC: 67AN: 152174Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
67
AN:
152174
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000980 AC: 24AN: 244864Hom.: 0 AF XY: 0.0000746 AC XY: 10AN XY: 133976
GnomAD3 exomes
AF:
AC:
24
AN:
244864
Hom.:
AF XY:
AC XY:
10
AN XY:
133976
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000377 AC: 55AN: 1459074Hom.: 0 Cov.: 34 AF XY: 0.0000276 AC XY: 20AN XY: 725916
GnomAD4 exome
AF:
AC:
55
AN:
1459074
Hom.:
Cov.:
34
AF XY:
AC XY:
20
AN XY:
725916
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000440 AC: 67AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.000403 AC XY: 30AN XY: 74456
GnomAD4 genome
AF:
AC:
67
AN:
152292
Hom.:
Cov.:
32
AF XY:
AC XY:
30
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
5-Oxoprolinase deficiency Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 09, 2022 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 08, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at